CX3C 趋化因子受体 1 (CX3CR1),也称为分形因子受体或 GPR13,是 CX3CL1 的特异性受体。顾名思义,CX3CR1 可与趋化因子 CX3CL1(也称为分形因子(在人类中)或神经触素(在小鼠中))结合。CX3CL1 是 CX3C 家族的成员,已在活化的内皮细胞、平滑肌细胞 (SMC)、巨噬细胞和血小板上检测到。CX3CL1 是体内唯一具有促炎、抗炎和神经保护作用的神经元趋化因子,并参与多种炎症病理的发展,包括动脉粥样硬化、类风湿性关节炎或移植排斥。
CX3C chemokine receptor1 (CX3CR1), also known as the fractalkine receptor or GPR13, is the specific receptor to the CX3CL1. As the name suggests, CX3CR1 binds the chemokine CX3CL1 (also called fractalkine (in humans) or neurotactin (in mouse) ). CX3CL1 is a member of the CX3C family and that has been detected on activated endothelial cells, smooth muscle cells (SMCs), macrophages and platelets. CX3CL1 is the only neuronal chemokine in the body with pro-inflammatory, anti-inflammatory and neuroprotective effects, and is involved in the development of numerous inflammatory pathologies including atherosclerosis, rheumatoid arthritis, or graft rejection.
CX3CR1-IN-2(Compound 77)是一种 IC50 值为 0.04 μM 的 CX3CR1 抑制剂,可阻断 CX3CR1 与其配体分形趋化因子(CX3CL1)之间的相互作用,并可用于心力衰竭和心肌病等心血管疾病的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号